Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Non-alcoholic Fatty Liver Disease
|
222 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.100 | 0.905 | 42 | 2014 | 2020 | ||||
Steatohepatitis
|
75 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.100 | 1.000 | 19 | 2015 | 2020 | ||||
Liver diseases
|
100 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.060 | 1.000 | 6 | 2015 | 2020 | ||||
Liver carcinoma
|
942 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.070 | 1.000 | 7 | 2016 | 2019 | ||||
Triglycerides measurement
|
1418 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.700 | 1.000 | 5 | 2015 | 2019 | ||||
Cardiovascular Diseases
|
711 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.040 | 1.000 | 4 | 2015 | 2019 | ||||
Hepatitis C
|
347 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.040 | 1.000 | 4 | 2016 | 2019 | ||||
Metabolic Syndrome X
|
591 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.030 | 1.000 | 3 | 2016 | 2019 | ||||
Serum total cholesterol measurement
|
1243 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.700 | 1.000 | 3 | 2015 | 2019 | ||||
Alcoholic Liver Diseases
|
20 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.020 | 1.000 | 2 | 2018 | 2019 | ||||
Chronic liver disease
|
14 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.020 | 1.000 | 2 | 2019 | 2019 | ||||
Hepatitis B
|
519 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.020 | 1.000 | 2 | 2016 | 2019 | ||||
Adenoma of large intestine
|
213 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Adult Liver Carcinoma
|
72 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Liver and Intrahepatic Biliary Tract Carcinoma
|
73 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Malignant neoplasm of liver
|
88 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Fatty Liver
|
35 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.100 | 1.000 | 11 | 2015 | 2018 | ||||
Cirrhosis
|
110 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.030 | 1.000 | 3 | 2015 | 2018 | ||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.720 | 1.000 | 3 | 2018 | 2018 | ||||
Liver Cirrhosis
|
189 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.030 | 1.000 | 3 | 2015 | 2018 | ||||
Nonalcoholic Steatohepatitis
|
17 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.020 | 1.000 | 2 | 2015 | 2018 | ||||
Adrenoleukodystrophy
|
116 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Chronic viral hepatitis
|
8 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Low density lipoprotein cholesterol measurement
|
1142 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||
Posterior subcapsular cataract
|
9 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2018 | 2018 |